Aptar’s N-Sorb Nitrosamine Mitigation Solution Granted US FDA’s Emerging Technology Program Approval

Aptar, a global leader in dispensing, sealing, and active packaging solutions, has announced that its N-Sorb Nitrosamine Mitigation Solution has been accepted into the US Food and Drug Administration’s (FDA) Emerging Technology Program. This program is designed to help expedite the development and review of innovative technologies that have the potential to significantly impact public health.

Nitrosamines are a group of chemical compounds that are classified as probable human carcinogens. They can be found in various consumer products, including pharmaceuticals, cosmetics, and food packaging. Aptar’s N-Sorb Nitrosamine Mitigation Solution is a cutting-edge technology that helps to mitigate the formation of nitrosamines in packaging materials, thus reducing the risk of exposure to these harmful compounds.

“We are thrilled that our N-Sorb Nitrosamine Mitigation Solution has been accepted into the FDA’s Emerging Technology Program,” said Stephan Tanda, CEO of Aptar. “This recognition underscores the importance of our innovation in addressing the critical issue of nitrosamine formation in packaging materials. We are committed to developing solutions that not only meet regulatory requirements but also prioritize consumer safety.”

By being accepted into the FDA’s Emerging Technology Program, Aptar’s N-Sorb Nitrosamine Mitigation Solution will benefit from increased communication and collaboration with the FDA throughout the development and review process. This will help to expedite the technology’s pathway to market, ultimately enabling manufacturers to bring safer products to consumers more quickly.

Overall, Aptar’s acceptance into the FDA’s Emerging Technology Program is a significant milestone for the company and further solidifies its position as a leader in innovative packaging solutions. With the N-Sorb Nitrosamine Mitigation Solution, Aptar is not only meeting regulatory requirements but also proactively addressing public health concerns, demonstrating its commitment to consumer safety and well-being.